A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT05648214 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Interventions

DRUG: ALN-PNP
DRUG: Placebo (PB)

Sponsor

Regeneron Pharmaceuticals